With the state’s commitment to the life sciences sector still tied up in an inter-branch dispute among Democrats, industry leaders acknowledged challenges on Tuesday including a record vacancy rate for lab space in Massachusetts, slower job growth, and a decrease in venture capital funding.
The MassBio trade group, in a new “industry snapshot‚” argued the headwinds are tempered by net job growth, the state’s prowess in the drug development pipeline and regional expansion of the sector beyond Cambridge.
